HSV Glycoprotein D [GST] (DAG535)

HSV Glycoprotein D [GST], recombinant protein from E. coli

Product Overview
Recombinant Herpes Simplex Virus-2 antigen (40.6 kDa), contains the HSV-2 gD immunodominant regions and a GST fusion partner, was expressed in E. coli, and puried in vitro using Metal affinity chromatography techniques.
Molecular Weight
40.6 kDa
> 95% pure (10% PAGE (coomassie staining). GS-4B Sepharose-Affinity Purification
Purified, Liquid
1 mg/ml
25mM Tris-HC1, pH 7.2, 1mM EDTA containing 50% glycerol
2-8°C short term, -20°C long term
Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family, Herpesviridae, that infect humans. Both HSV-1 (which produces most cold sores) and HSV-2 (which produces most genital herpes) are ubiquitous and contagious. They can be spread when an infected person is producing and shedding the virus.
Antigen Description
Glycoprotein D(gD) binds specifically to the herpesvirus entry mediator receptor (HVEM), thus providing a strong, fixed attachment to the host cell. These interactions bring the membrane surfaces into mutual proximity and allow for other surface glycoproteins to interact.
Herpesviridae; Alphaherpesvirinae; Simplexvirus; Herpes simplex virus 1; HSV-1; Herpes simplex virus 2; HSV-2; Herpes simplex virus; HSV 1&2; Herpes Simplex Virus Type 1 & 2; HSV1 + HSV2 gD; Envelope glycoprotein D; GD; Glycoprotein D; US6


Have you cited DAG535 in a publication? Let us know and earn a reward for your research.

Customer Reviews

Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket


York, LJ; Giorgio, DP; et al. Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: Implications for immunotherapy of recurrent HSV infection. VACCINE 13:1706-1712(1995).
Fujii, G; Ernst, W; et al. The VesiVax system: a method for rapid vaccine development. FRONTIERS IN BIOSCIENCE-LANDMARK 13:1968-1980(2008).

Online Inquiry

Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:
Verification code
Click image to refresh the verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket